[HTML][HTML] Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
Background In this phase I/II trial, we evaluated the safety and effectiveness of
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
[HTML][HTML] Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma, C Tang… - … for ImmunoTherapy of …, 2020 - jitc.bmj.com
Background In this phase I/II trial, we evaluated the safety and effectiveness of
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
[PDF][PDF] Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma, C Tang, M Altan… - scholar.archive.org
Background In this phase I/II trial, we evaluated the safety and effectiveness of
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma… - Journal for …, 2020 - search.proquest.com
Background In this phase I/II trial, we evaluated the safety and effectiveness of
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.
J Welsh, H Menon, D Chen, V Verma… - … for Immunotherapy of …, 2020 - europepmc.org
Background In this phase I/II trial, we evaluated the safety and effectiveness of
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma, C Tang… - … for ImmunoTherapy of …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> In this phase I/II trial, we
evaluated the safety and effectiveness of pembrolizumab, with or without concurrent …
evaluated the safety and effectiveness of pembrolizumab, with or without concurrent …
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: A randomized phase I/II trial
J Welsh, H Menon, D Chen… - Journal for …, 2020 - mdanderson.elsevierpure.com
Background In this phase I/II trial, we evaluated the safety and effectiveness of
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma… - Journal for …, 2020 - pubmed.ncbi.nlm.nih.gov
Background In this phase I/II trial, we evaluated the safety and effectiveness of
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …
pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from …